Change
Tools:
Print this page Compare to last year's report

Consolidated statement of income


3rd quarter

 

 

 

January - September

2012

 

2013

 

in € millions

 

2012

 

2013

 

 

 

 

 

 

 

 

 

Continuing operations

3,966

 

3,778

 

Revenue

 

11,717

 

11,108

(2,447)

 

(2,296)

 

Cost of sales

 

(7,233)

 

(6,753)

1,519

 

1,482

 

Gross profit

 

4,484

 

4,355

(2,106)

 

 

Impairment

 

(2,106)

 

(829)

 

(763)

 

Selling expenses

 

(2,373)

 

(2,256)

(313)

 

(311)

 

General and administrative expenses

 

(917)

 

(965)

(98)

 

(92)

 

Research and development expenses

 

(285)

 

(276)

(31)

 

(13)

 

Other operating income/(expenses)

 

(37)

 

(16)

(1,858)

 

303

 

Operating income

 

(1,234)

 

842

(50)

 

(56)

 

Net financing expenses

 

(167)

 

(152)

5

 

4

 

Results from associates and joint ventures

 

14

 

13

(1,903)

 

251

 

Profit before tax

 

(1,387)

 

703

(64)

 

(83)

 

Income tax

 

(219)

 

(90)

(1,967)

 

168

 

Profit for the period from continuing operations

 

(1,606)

 

613

 

 

 

 

 

 

 

 

 

Discontinued operations

(392)

 

1

 

Profit for the period from discontinued operations

 

(414)

 

115

(2,359)

 

169

 

Profit for the period

 

(2,020)

 

728

 

 

 

 

 

 

 

 

 

Attributable to

(2,368)

 

155

 

Shareholders of the company

 

(2,065)

 

673

9

 

14

 

Non-controlling interests

 

45

 

55

(2,359)

 

169

 

Profit for the period

 

(2,020)

 

728

Copyright © 2013 Akzo Nobel N.V.